Feedback / Questions
VLS-1488 - Volastra Therap
https://www.businesswire.com/news/home/20250522033030/en/Volastra-Announces-Initial-Data-from-First-in-Human-Phase-III-Trial-of-Novel-KIF18A-Inhibitor-VLS-1488-to-be-Presented-at-2025-ASCO-Annual-Meeting
May 22, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next